4.75
1.55%
-0.075
scPharmaceuticals Inc Aktie (SCPH) Neueste Nachrichten
HC Wainwright Weighs in on scPharmaceuticals Inc.'s Q2 2024 Earnings (NASDAQ:SCPH) - Defense World
Defense World
Q2 2024 Earnings Estimate for scPharmaceuticals Inc. Issued By HC Wainwright (NASDAQ:SCPH) - MarketBeat
MarketBeat
scPharmaceuticals Inc. Expected to Earn FY2027 Earnings of $1.95 Per Share (NASDAQ:SCPH) - Defense World
Defense World
scPharmaceuticals (NASDAQ:SCPH) Rating Reiterated by HC Wainwright - Defense World
Defense World
Analysts Issue Forecasts for scPharmaceuticals Inc.'s FY2026 Earnings (NASDAQ:SCPH) - Defense World
Defense World
Ratio Revelations: scPharmaceuticals Inc (SCPH)'s Financial Metrics in the Spotlight – DWinneX - The Dwinnex
The Dwinnex
scPharmaceuticals Inc. Expected to Post FY2027 Earnings of $1.95 Per Share (NASDAQ:SCPH) - MarketBeat
MarketBeat
Was anything positive for scPharmaceuticals Inc (SCPH) stock last session? – US Post News - US Post News
US Post News
scPharmaceuticals' (SCPH) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
MarketBeat
scPharmaceuticals (NASDAQ:SCPH) Posts Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
MarketBeat
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates - MSN
MSN
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Yahoo Finance
scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.
scPharmaceuticals reports Q1 EPS (36c), consensus (44c) - TipRanks.com - TipRanks
TipRanks
scPharmaceuticals to Present at the H.C. Wainwright 2nd - GlobeNewswire
GlobeNewswire
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewswire Inc.
scPharmaceuticals (SCPH) Scheduled to Post Earnings on Tuesday - Defense World
Defense World
scPharmaceuticals (SCPH) to Release Quarterly Earnings on Tuesday - MarketBeat
MarketBeat
scPharmaceuticals (SCPH) to Release Quarterly Earnings on Tuesday - MarketBeat
MarketBeat
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024 - GlobeNewswire
GlobeNewswire
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024
GlobeNewswire Inc.
SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Raymond James & Associates Raises Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Defense World
scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector ... - Yahoo Finance
Yahoo Finance
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
GlobeNewswire Inc.
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
GlobeNewswire Inc.
SCPH Stock Quote Price and Forecast - CNN
CNN
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
GlobeNewswire Inc.
scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
GlobeNewswire Inc.
scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue - GlobeNewswire
GlobeNewswire
scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 - Yahoo Finance
Yahoo Finance
scPharmaceuticals (SCPH): Furoscix, Charting A Bright Future With FDA's Nod For CKD - Seeking Alpha
Seeking Alpha
scPharmaceuticals: Furoscix Launch And Market Access; A Promising Outlook - Seeking Alpha
Seeking Alpha
scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection) - GlobeNewswire
GlobeNewswire
scPharma (SCPH) Stock: Undervalued, De-Risked Cardiology Commercial Biotech - Seeking Alpha
Seeking Alpha
scPharmaceuticals: Furoscix Approval A Potential Paradigm Shift For Heart Failure Patients - Seeking Alpha
Seeking Alpha
Money on the Move: Vita, scPharmaceuticals, Andera and More - BioSpace
BioSpace
scPharmaceuticals Announces $100 Million Debt Financing Agreement with Oaktree - GlobeNewswire
GlobeNewswire
scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific ... - Diagnostic and Interventional Cardiology
Diagnostic and Interventional Cardiology
scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure - Diagnostic and Interventional Cardiology
Diagnostic and Interventional Cardiology
3rd time lucky? ScPharmaceuticals gets decision date for twice-rejected on-body drug delivery product - FiercePharma
FiercePharma
scPharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update - citybiz
citybiz
Ace heart-wear store Scpharma wields proven tool for cardiac cost saving - BioWorld Online
BioWorld Online
Kapitalisierung:
|
Volumen (24h):